Ropes & Gray represented Arbor Biotechnologies in the transaction. Arbor Biotechnologies announced its $73.9 million Series C financing to support the advancement of its novel gene...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Arbor Biotechnologies in the transaction. Arbor Biotechnologies announced a strategic partnership with 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT). As part of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Arbor Biotechnologies on the deal. Arbor Biotechnologies announced an oversubscribed and up-sized $215 million Series B financing. Arbor plans to use the...
You must be a Standard 1 Year member to access this content.
